ObjectiveTo summarize the current progress of clinical therapy for hemifacial microsomia (HFM). MethodsThe domestic and overseas articles concerning the treatment of HFM were reviewed and analyzed. ResultsThe unified therapeutic schedule of HFM has not yet been determined due to its variable clinical manifestation. Therapies mainly include: correction of bone deformity, which attain high effectiveness by adopting distraction osteogenesis or the improvement approach based on it; repair of the hypoplasia of facial soft tissue using graft of free tissue or autologous fat, augmentation of prosthesis materials. Autologous fat is becoming a hot research area and is widely used in recent years. For the aspect of treatment of microtia, different methods are adopted according to the severity of the malformation. ConclusionThe uniform clinical diagnosis and therapy of HFM are not determined for its complicated classification and unknown etiology. The research of etiology and tissue engineering may provide the therapy of HFM.
Hemifacial microsomia (HFM) is a developmental hypoplasia of one side of face and ear due to congenital hypoplasia. At present, the causes of HFM have not been completely clarified, the classification methods are diverse, and the diagnosis and treatment methods are complex. Through reviewing the relevant study on the treatment of HFM domestic and overseas in recent years, the possible etiology and corresponding clinical manifestations of the disease are analyzed, and the existing clinical classification methods, treatment strategies and latest research results are summarized.